Sponsor pipeline

Shanghai Hengrui Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Shanghai Hengrui Pharmaceutical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

Show 2 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
7
Phase 1/2
10
Phase 2
6
Phase 3
2

Disease areas by active trials

Bladder Cancer (4) · Lung Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (2) · Breast Cancer (1) · Esophageal Cancer (1) · Multiple Myeloma (1) · Pancreatic Cancer (1) · Small Cell Lung Cancer (1)

Get alerts when Shanghai Hengrui Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free